Stefani Spranger

25PUBLICATIONS
107CO-AUTHORS
Predictive and prognostic markersBiologically active moleculesInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 24, 2026
Modeling lung adenocarcinoma using layer-by-layer nanoparticles mitigates innate immune cell activation.

|Feb 19, 2026
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.

Grayson E Rodriguez, Yang Zhao, Yoko Nishiga

|Feb 12, 2026
Lymph node resident memory T cells retain effector capabilities by evading lung resident memory dysfunction.

Taylor A Heim, Zachary J Rogers, Sarah Duquette

|Feb 12, 2026
The CD8 immgenT framework as a universal reference of mouse CD8αβ T cell differentiation states.

Giovanni Galletti, Anna-Maria Globig, Olga Barreiro

|Dec 15, 2025
PD-1 blockade during T cell priming enhances long-term protection against metastatic tumors by epigenetically tuning T cell exhaustion.

Teresa Dinter, Sebastian Mackowiak, Zachary J Rogers

|Dec 03, 2025
Buoyant mass reveals distinct T cell states predictive of checkpoint response.

Jiaquan Yu, Ye Zhang, Sarah M Duquette

Pageof 5

Frequent Collaborators

4 joint publications

Vidit Bhandarkar

4 joint publications

J Christopher Love

4 joint publications

K Dane Wittrup

3 joint publications

Forest M White